PRESS RELEASE: Aquarius Population Health wins a prestigious SBRI grant from Innovate UK

Work has begun to develop a digital value proposition tool for a novel rapid sexually transmitted infection (STI) test

London, UK, 14 August 2017

Aquarius Population Health, a leading independent health economics consultancy, has recently been awarded an 18-month Innovate UK grant in collaboration with Atlas Genetics Ltd and the Applied Diagnostic Research and Evaluation Unit at St George’s University of London (total £2,000,000). The funding will be used to develop evidence for health services to support the introduction of a new rapid diagnostic test. In 30-minutes the test can diagnose multiple sexually transmitted infections including chlamydia and gonorrhoea – infections which could take up to a week to diagnose using the current laboratory testing systems.

Continue reading

Point of care testing: Disruptive innovation – is the NHS ready for it yet?

Elisabeth AdamsOur Managing Director, Elisabeth Adams, spoke in November about the importance of exploring the health economics of point of care testing (POCT) at the Royal Society of Medicine Telemedicine and eHealth event in London. The video of her presentation is now online – view the full talk here.

Why is it important to explore the health economics of point of care testing (POCT)?

Evaluating the health economics of POCTs can help us better understand the cost, benefits and value of implementing these tests, compared to standard laboratory tests. We need to explore the acquisition costs of innovative technology like POCTs compared to standard tests, as well as the benefits generated for patients, service providers, clinicians and public health in general. Benefits can include faster results, better care, fewer complications, more efficient services and better use of resources, and knock-on benefits like reduced prevalence of disease. Those making purchasing decisions for new tests need evidence to prove the value of the tests.

Continue reading

Aquarius Population Health presents the breast cancer diagnostic pathway at ISPOR Milan

Our Managing Director, Dr Elisabeth Adams, will be presenting “Mapping the diagnostic pathway for breast cancer in England and comparison to Europe” at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Milan which runs from the 7 – 11 November, 2015.

Continue reading

Rapid on-demand testing of HPV and cervical cancer prevention: IPV Conference in Lisbon

Our managing director, Dr Elisabeth Adams, is presenting two posters at the 30th annual International Papillomavirus Conference  in Lisbon, Portugal.  The first poster, “Exploring the value of a rapid, on-demand test for the detection of human papillomavirus”, is a detailed look at the current patient pathways for cervical screening programmes, and key opinion leaders’ views on the impact a rapid diagnostic would have on the health and overall wellbeing of women.

Continue reading

Cancer

Optimising cancer pathways

Pathways for the diagnosis, treatment and follow-up of patients with cancer are complex. Cancer care information is held in different sites, making a holistic view to care challenging. We visualise the different routes to diagnosis and treatment, and quantify the burden to the healthcare system.  This provides a more complete understanding of the opportunities for introducing innovation and improvement into cancer care resulting in better outcomes for patients and more efficient services.

Read more